Status:
COMPLETED
Reactions to E-cigs and Alcohol
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Abuse
Nicotine Dependence Tobacco Product
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to 1) examine cognitive acuity following e-cig use (as compared to no e-cig use), 2) examine motor coordination following beer and e-cig use (as compared to beer consumpti...
Detailed Description
Participants will be recruited via study fliers and notices in the community and via word-of-mouth. After viewing study advertisements, participants will call the lab and complete an over the phone sc...
Eligibility Criteria
Inclusion
- Healthy men and women, 21 years of age or older
- Regular alcohol use (reports at least one drink weekly - acceptability of average alcohol consumption will be made on a case by case basis by the PI)
- No current/prior severe alcohol or substance use disorder (endorsement of \> 6 Alcohol/Drug Use history items on the phone screen)
- Current e-cigarette use (reports at least weekly use - acceptability of average e-cig use will be made on a case by case basis by the PI)
- Able to understand questionnaires/procedures in English
- Reports drinking beer (Yes/No on phone screen)
Exclusion
- Pregnant/breast-feeding women (assessed via phone screen and urine screen)
- Unstable or significant medical disorders that may influence study outcome or participant safety as determined by Melissa Cyders (e.g., liver condition)
- Current/prior severe alcohol use disorder, current/prior severe substance use disorder (endorsement of \> 6 Alcohol/Drug Use history items on the phone screen)
- Positive urine drug screen for amphetamines/meth-amphetamines, barbiturates, benzodiazapines, cocaine, opiates, or PCP \[1-phenylcyclohexyl\]
- Current mental health problems, such as depression, anxiety, post-traumatic stress disorder, bipolar disorder, or schizophrenia (self-reported at phone screen)
- Positive BrAC reading at the start of any study visit
- Court-mandated order to not drink alcohol
- Any condition that, in the judgment of the PI, could place the participant at risk or affect data validity
Key Trial Info
Start Date :
March 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03449017
Start Date
March 24 2017
End Date
November 11 2018
Last Update
November 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana Univerisity Purdue University Indianapolis
Indianapolis, Indiana, United States, 46202